The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.
This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy medication. The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the Food and Drug Administration said Friday.This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy medication.
The move will change the way many heart patients are treated, said Dr. Martha Gulati, a cardiologist at Cedars-Sinai Medical Center in Los Angeles. It confirms that the new class of obesity medications are useful for improving health, not just losing weight. About a third of the more than 17,600 participants in the clinical trial reported serious side effects. About 17% in the group that took Wegovy and about 8% of those who received placebo left the study because of those effects.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA approves Wegovy to reduce heart attack and stroke riskBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Les mer »
FDA approves Wegovy for cardiovascular diseaseThe FDA on Friday approved Wegovy to lower the risk of cardiovascular death for people who are obese or overweight, a first of its kind classification.
Les mer »
Novo Nordisk settles two lawsuits over copycat versions of Ozempic and WegovyBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Les mer »
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Les mer »
Wegovy, Ozempic Use Could Complicate Your SurgeryWeight-loss drugs like Wegovy and Ozempic can increase a person’s risk of throwing up during surgery while under anesthesia, a new study reports.
Les mer »
More teens are using weight loss drugs like Wegovy and OzempicMarina Kopf is an associate producer with the NBC News Health and Medical Unit.
Les mer »